患有COPD的人体活动和系统生物标志物:基于Web的计步仪介导干预的见解
Megan N Berube1, Stephanie A Robinson2,3, Emily S Wan1,4,5,6
1Research and Development Service, VA Boston Healthcare System, Boston, Massachusetts, United States.
Chronic obstructive pulmonary diseases (Miami, Fla.)
|May 29, 2024
概括
身体活动和运动表现与COPD患者的心肌压力生物标志物相关. 3个月的步行计划并没有显著改变这些全身生物标志物.
科学领域:
- 肺部医学 肺部医学
- 心血管健康 心血管健康
- 运动生理学 运动生理学
背景情况:
- 慢性阻塞性肺病 (COPD) 与复杂的系统性影响有关.
- 身体活动 (PA),运动表现和COPD系统生物标志物之间的相互作用尚未得到充分理解.
- 在COPD中,PA促进对心肌压力,炎症和肌肉损伤的生物标志物的影响需要进一步研究.
研究的目的:
- 研究COPD患者体力活动,运动表现和系统生物标志物之间的关系.
- 确定PA促进干预对反映心肌应激 (NT-proBNP),全身炎症 (sRAGE) 和肌肉损伤 (CKMM) 的生物标志物的影响.
主要方法:
- 对3项先前研究的二次分析,涉及366名美国退伍军人患有COPD.
- 评估每日步数 (PA) 和6分钟步行测试 (6MWT) 对于运动表现.
- 在基线和3个月测量血清NT-proBNP,sRAGE和CKMM,使用一般线性模型分析关联和干预效应.
主要成果:
- 较低的基线NT-proBNP与更高的每日步数和更大的6MWT距离有关.
- 与对照组相比,为期3个月的社区步行干预显著增加了每日步数.
- 该PA干预没有导致NT-proBNP,sRAGE或CKMM的显著变化.
结论:
- 运动表现,特别是6MWT距离,与COPD患者的NT-proBNP水平有关.
- 一个为期3个月的基于社区的步行干预没有显示出对心肌压力或肌肉损伤生物标志物的显著影响.
- 需要进一步的研究来探索有效的PA干预措施,以改善COPD的系统生物标志物.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


